Position in BIIB
as of Jun 30, 2026
· filed Jul 16, 2026
Position Value
$20,957
-$5,625 QoQ
Shares Held
97
-33.1% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#874
of 1,031 holders
Holding Since
Dec 2021
12 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BIIB Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026STEPH & CO holds $2,307,781 across 8 Drug Manufacturers - General names. BIIB ranks #7 (0.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
3,734 | $948,323 | |
| 2 | GILD |
Gilead Sciences, Inc.
|
3,799 | $479,965 | |
| 3 | BMY |
Bristol Myers Squibb Co
|
8,045 | $463,552 | |
| 4 | ABBV |
AbbVie Inc.
|
1,250 | $314,550 | |
| 5 | PFE |
Pfizer Inc
|
1,695 | $40,815 | |
| 6 | GSK |
GSK plc
|
527 | $27,625 | |
| 7 | BIIB |
Biogen Inc.
This page
|
97 | $20,957 | |
| 8 | LLY |
ELI LILLY & Co
|
10 | $11,994 |
All Filings in BIIB
Export CSV
12 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $20,957 | 97 | Shares | Sole | 2026-07-16 | |
| 2026-03-31 | $26,582 | 145 | Shares | Sole | 2026-04-17 | |
| 2025-12-31 | $24,110 | 137 | Shares | Sole | 2026-01-23 | |
| 2025-09-30 | $11,066 | 79 | Shares | Sole | 2025-10-06 | |
| 2025-06-30 | $9,419 | 75 | Shares | Sole | 2025-07-16 | |
| 2025-03-31 | $10,263 | 75 | Shares | Sole | 2025-04-23 | |
| 2024-12-31 | $5,505 | 36 | Shares | Sole | 2025-01-14 | |
| 2024-09-30 | $14,925 | 77 | Shares | Sole | 2024-10-15 | |
| 2024-06-30 | $12,054 | 52 | Shares | Sole | 2024-07-30 | |
| 2024-03-31 | $10,350 | 48 | Shares | Sole | 2024-04-12 | |
| 2022-03-31 | $17,479 | 83 | Shares | Sole | 2022-04-15 | |
| 2021-12-31 | $19,913 | 83 | Shares | Sole | 2022-01-24 | |
| No filing history on record for this holder in this stock. | ||||||